Resultados da pesquisa - Stephan Weidinger

Letter to the editor submitted in response to ‘Are potential remittive properties of OX-40 inhibitors something to be excited about?’ Por Andrew Blauvelt, Thomas Bieber, Stephan Weidinger, Raj Chovatiya, Kassim Rahawi

Obter o texto integral

Treatment of Moderate-to-severe Atopic Dermatitis with Upadacitinib: Results from an Interim Analysis of the TREATgermany Registry Por Barbara Kind, Luise Heinrich, Thomas Werfel, Jochen Schmitt, Stephan Weidinger

Obter o texto integral

Tolerability of Narrow-band Ultraviolet-B Phototherapy for Different Dermatological Diseases in Relation to Co-medications Por Anna M. Halupczok, Ann-Sophie Bohne, Sascha Gerdes, Stephan Weidinger, Michael Weichenthal

Obter o texto integral

Tailoring Abrocitinib Treatment for Moderate-to-Severe Atopic Dermatitis to Patient Disease Course: A Narrative Review Por Jonathan I. Silverberg, Eric Simpson, Melinda Gooderham, Stephan Weidinger, Melissa Watkins, Justine Alderfer

Obter o texto integral

An unusual granulomatous tinea due to Nannizzia incurvata in Germany without evidence of an acquisition from outside Europe and reduced itraconazole susceptibility Por Elisabeth Anke Schuldt, Karen Voss, Thomas Schwarz, Stephan Weidinger, Dora Violetta Stölzl, Jochen Brasch

Obter o texto integral

Type 2 Cytokine–Dependent Skin Barrier Regulation in Personalized 2-Dimensional and 3-Dimensional Skin Models of Atopic Dermatitis: A Pilot Study Por Hila Emmert, Franziska Rademacher, Matthias Hübenthal, Regine Gläser, Hanne Norsgaard, Stephan Weidinger, Jürgen Harder

Obter o texto integral

Bullous lichen sclerosus: A rare differential diagnosis of a blistering genital dermatosis Por Sissy-Alina Waschkowski, MD, Merit Kaeding, MD, Thomas Schwarz, MD, Stephan Weidinger, MD, Katharina Boch, MD

Obter o texto integral

Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE Por Jonathan I. Silverberg, Eric L. Simpson, Andrew E. Pink, Stephan Weidinger, Gary Chan, Pinaki Biswas, Claire Clibborn, Erman Güler

Obter o texto integral

In Vitro Evidence Demonstrating the Nondepleting Mechanism of Action of Amlitelimab, an OX40 Ligand Monoclonal Antibody Por James G. Krueger, Brian S. Kim, Stephan Weidinger, Yoko Kataoka, John T. O'Malley, Karl Yen, Cassie Van Krinks, Jose Vela

Obter o texto integral

Early Achievement of High Treatment Targets in Moderate-to-Severe Atopic Dermatitis with Upadacitinib: Real-World Evidence from the Observational UP-TAINED Study Por Stephan Weidinger, Tobias Schadeck, Felix Jacobs, Ansgar Weyergraf, Dariusch Mortazawi, Tobias Hagemann, Fatima Abousamra, Thomas Mosch, Bjoern Fritz, Felix Lauffer

Obter o texto integral

Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis Por Emma Guttman-Yassky, Thomas Bieber, Kenji Kabashima, Jan Gutermuth, Stephan Weidinger, Andreas Wollenberg, Irina Lazariciu, Gerardo Encinas, Marina Mikheil, Melissa Watkins

Obter o texto integral

A Post Hoc Analysis of Atopic Dermatitis of the Head and Neck and Other Body Regions from the Amlitelimab STREAM-AD Phase 2b Study Por Adam Reich, Andrew Blauvelt, Stephan Weidinger, Vivian Y. Shi, Norito Katoh, Charles Lynde, Xinghua Gao, Nicole M. Armstrong, Charlotte Bernigaud, Kassim Rahawi

Obter o texto integral

Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis Por Regina Fölster-Holst, Rahel Reimer, Claudia Neumann, Erhardt Proksch, Elke Rodriguez, Stephan Weidinger, Mohamad Goldust, Eckhard Hanisch, Stephan Dähnhardt-Pfeiffer, Sandra Freitag-Wolf

Obter o texto integral

Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis Por Gilles Tiraboschi, Kim Papp, Thomas Bieber, Stephan Weidinger, Lisa Beck, Chih‐Hung Lee, John T. O'Malley, Karl Yen, Charlotte Bernigaud, David Fabre, Fabrice Hurbin

Obter o texto integral

Similarities and Differences in the Perception of Atopic Dermatitis Burden Between Patients, Caregivers, and Independent Physicians (AD-GAP Survey) Por Amy S. Paller, Stephan Weidinger, Korey Capozza, Andrew E. Pink, Mark Tang, Xavier Guillaume, Amy Praestgaard, Marjorie Leclerc, Chien-Chia Chuang, Ryan B. Thomas, Randy Prescilla

Obter o texto integral

Tobacco smoking leads to extensive genome-wide changes in DNA methylation. Por Sonja Zeilinger, Brigitte Kühnel, Norman Klopp, Hansjörg Baurecht, Anja Kleinschmidt, Christian Gieger, Stephan Weidinger, Eva Lattka, Jerzy Adamski, Annette Peters, Konstantin Strauch, Melanie Waldenberger, Thomas Illig

Obter o texto integral

Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations Por Melinda J. Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, Michael J. Cork, Lawrence F. Eichenfield, Eric L. Simpson, Athanasios Tsianakas, Urs Kerkmann, Claire Feeney, William Romero

Obter o texto integral

Efficacy of lebrikizumab in adolescent patients with moderate-to-severe atopic dermatitis: 16-week results from three randomized phase 3 clinical trials Por Adelaide A. Hebert, Carsten Flohr, H. Chih-ho Hong, Alan D. Irvine, Evangeline Pierce, Hany Elmaraghy, Sreekumar Pillai, Zach Dawson, Sherry Chen, Clara Armengol, Elaine Siegfried, Stephan Weidinger

Obter o texto integral

Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated w... Por Shawn G. Kwatra, Marjolein de Bruin-Weller, Jonathan I. Silverberg, Peter Lio, Mette Deleuran, Handan Aydin, Brian M. Calimlim, Michael C. Lane, Yingyi Liu, Sarah Ofori, Stephan Weidinger

Obter o texto integral

Safety and Efficacy of Lebrikizumab in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis: A 52-Week, Open-Label, Phase 3 Study Por Amy S. Paller, Carsten Flohr, Lawrence F. Eichenfield, Alan D. Irvine, Jamie Weisman, Jennifer Soung, Ana Pinto Correia, Chitra R. Natalie, Claudia Rodriguez Capriles, Evangeline Pierce, Sarah Reifeis, Renata Gontijo Lima, Clara Armengol Tubau, Vivian Laquer, Stephan Weidinger

Obter o texto integral